Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication.

Revista da Escola de Enfermagem da U S P

Schlottfeldt Fdos S, Fernandes SM, Martins DM, Cordeiro P, Fonseca CD, Watanabe M, Vattimo Mde F.
PMID: 26761695
Rev Esc Enferm USP. 2015 Feb;49:74-9. doi: 10.1590/S0080-623420150000700011.

Objective To evaluate the effect of diosmin and hesperidin flavonoids in the prevention of amphotericin B nephrotoxicity, through an experimental model on rats. Method Adult, male Wistar rats were distributed into the following groups: saline; diosmin hesperidin (animals that...

Cite
Schlottfeldt Fdos S, Fernandes SM, Martins DM, et al. Prevenção da nefrotoxicidade da anfotericina B por meio do uso de fitomedicamentos. Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication. Rev Esc Enferm USP. 2015;49:74-9doi: 10.1590/S0080-623420150000700011.
Schlottfeldt, F. d. o. s. . S., Fernandes, S. M., Martins, D. M., Cordeiro, P., Fonseca, C. D., Watanabe, M., & Vattimo, M. d. e. . F. (2015). Prevenção da nefrotoxicidade da anfotericina B por meio do uso de fitomedicamentos. Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication. Revista da Escola de Enfermagem da U S P, 4974-9. https://doi.org/10.1590/S0080-623420150000700011
Schlottfeldt, Fábio Dos Santos, et al. "Prevenção da nefrotoxicidade da anfotericina B por meio do uso de fitomedicamentos." Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication. Revista da Escola de Enfermagem da U S P vol. 49 (2015): 74-9. doi: https://doi.org/10.1590/S0080-623420150000700011
Schlottfeldt Fdos S, Fernandes SM, Martins DM, Cordeiro P, Fonseca CD, Watanabe M, Vattimo Mde F. Prevenção da nefrotoxicidade da anfotericina B por meio do uso de fitomedicamentos. Prevention of amphotericin B nephrotoxicity through use of phytotherapeutic medication. Rev Esc Enferm USP. 2015 Feb;49:74-9. doi: 10.1590/S0080-623420150000700011. Portuguese. PMID: 26761695.
Copy Download .nbib Format: NLM
The translation of knowledge as a subsidy for the nursing practice.

Revista brasileira de enfermagem

Vattimo MFF, Fonseca CDD.
PMID: 31269119
Rev Bras Enferm. 2019 Jun 27;72(3):582-583. doi: 10.1590/0034-7167.2019720301.

No abstract available.

Cite
Vattimo MFF, Fonseca CDD. The translation of knowledge as a subsidy for the nursing practice. Rev Bras Enferm. 2019;72(3):582-583doi: 10.1590/0034-7167.2019720301.
Vattimo, M. F. F., & Fonseca, C. D. D. (2019). The translation of knowledge as a subsidy for the nursing practice. Revista brasileira de enfermagem, 72(3), 582-583. https://doi.org/10.1590/0034-7167.2019720301
Vattimo, Maria de Fatima Fernandes, and Fonseca, Cassiane Dezoti da. "The translation of knowledge as a subsidy for the nursing practice." Revista brasileira de enfermagem vol. 72,3 (2019): 582-583. doi: https://doi.org/10.1590/0034-7167.2019720301
Vattimo MFF, Fonseca CDD. The translation of knowledge as a subsidy for the nursing practice. Rev Bras Enferm. 2019 Jun 27;72(3):582-583. doi: 10.1590/0034-7167.2019720301. Portuguese, Spanish. PMID: 31269119.
Copy Download .nbib Format: NLM
Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance.

Leukemia & lymphoma

Molica S, Dattilo A, Alberti A.
PMID: 21269073
Leuk Lymphoma. 1991;5(2):139-44. doi: 10.3109/10428199109068117.

The expression of myelomonocytic (My+) associated antigens on lymphocytes from B-chronic lymphocytic leukemia (B-CLL) was studied in 62 patients. Most of them expressed at least a My(+) antigen: CD11b in 40 cases (64.2%), CD13 in 31 (50%), CD14 in...

Cite
Molica S, Dattilo A, Alberti A. Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance. Leuk Lymphoma. 1991;5(2):139-44doi: 10.3109/10428199109068117.
Molica, S., Dattilo, A., & Alberti, A. (1991). Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance. Leukemia & lymphoma, 5(2), 139-44. https://doi.org/10.3109/10428199109068117
Molica, S, et al. "Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance." Leukemia & lymphoma vol. 5,2 (1991): 139-44. doi: https://doi.org/10.3109/10428199109068117
Molica S, Dattilo A, Alberti A. Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance. Leuk Lymphoma. 1991;5(2):139-44. doi: 10.3109/10428199109068117. PMID: 21269073.
Copy Download .nbib Format: NLM
Ecchymosis in a 16-year-old girl with anorexia and hypovitaminosis C.

Pediatrics and neonatology

Iacono A, Attico A, Biserna L, Marchetti F.
PMID: 34666961
Pediatr Neonatol. 2021 Oct 07; doi: 10.1016/j.pedneo.2021.08.011. Epub 2021 Oct 07.

No abstract available.

Cite
Iacono A, Attico A, Biserna L, et al. Ecchymosis in a 16-year-old girl with anorexia and hypovitaminosis C. Pediatr Neonatol. 2021;doi: 10.1016/j.pedneo.2021.08.011.
Iacono, A., Attico, A., Biserna, L., & Marchetti, F. (2021). Ecchymosis in a 16-year-old girl with anorexia and hypovitaminosis C. Pediatrics and neonatology, . https://doi.org/10.1016/j.pedneo.2021.08.011
Iacono, Alessandra, et al. "Ecchymosis in a 16-year-old girl with anorexia and hypovitaminosis C." Pediatrics and neonatology vol. (2021). doi: https://doi.org/10.1016/j.pedneo.2021.08.011
Iacono A, Attico A, Biserna L, Marchetti F. Ecchymosis in a 16-year-old girl with anorexia and hypovitaminosis C. Pediatr Neonatol. 2021 Oct 07; doi: 10.1016/j.pedneo.2021.08.011. Epub 2021 Oct 07. PMID: 34666961.
Copy Download .nbib Format: NLM
Inflammation: improving understanding to prevent or ameliorate kidney diseases.

The journal of venomous animals and toxins including tropical diseases

Fernandes SM, Watanabe M, Vattimo MFF.
PMID: 34712277
J Venom Anim Toxins Incl Trop Dis. 2021 Oct 18;27:e20200162. doi: 10.1590/1678-9199-JVATITD-2020-0162. eCollection 2021.

Inflammatory processes are believed to play an important role in immune response to maintain tissue homeostasis by activating cellular signaling pathways and releasing inflammatory mediators in the injured tissue. Although acute inflammation can be considered protective, an uncontrolled inflammation...

Cite
Fernandes SM, Watanabe M, Vattimo MFF. Inflammation: improving understanding to prevent or ameliorate kidney diseases. J Venom Anim Toxins Incl Trop Dis. 2021;27:e20200162doi: 10.1590/1678-9199-JVATITD-2020-0162.
Fernandes, S. M., Watanabe, M., & Vattimo, M. F. F. (2021). Inflammation: improving understanding to prevent or ameliorate kidney diseases. The journal of venomous animals and toxins including tropical diseases, 27e20200162. https://doi.org/10.1590/1678-9199-JVATITD-2020-0162
Fernandes, Sheila Marques, et al. "Inflammation: improving understanding to prevent or ameliorate kidney diseases." The journal of venomous animals and toxins including tropical diseases vol. 27 (2021): e20200162. doi: https://doi.org/10.1590/1678-9199-JVATITD-2020-0162
Fernandes SM, Watanabe M, Vattimo MFF. Inflammation: improving understanding to prevent or ameliorate kidney diseases. J Venom Anim Toxins Incl Trop Dis. 2021 Oct 18;27:e20200162. doi: 10.1590/1678-9199-JVATITD-2020-0162. eCollection 2021. PMID: 34712277; PMCID: PMC8525891.
Copy Download .nbib Format: NLM
Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Questions.

Pediatric nephrology (Berlin, Germany)

Mathew G, Yasmeen MS, Deepthi RV, Swain M, Vattam A, Shah MA, Agarwal I.
PMID: 34999981
Pediatr Nephrol. 2022 Jan 09; doi: 10.1007/s00467-021-05357-5. Epub 2022 Jan 09.

No abstract available.

Cite
Mathew G, Yasmeen MS, Deepthi RV, et al. Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Questions. Pediatr Nephrol. 2022;doi: 10.1007/s00467-021-05357-5.
Mathew, G., Yasmeen, M. S., Deepthi, R. V., Swain, M., Vattam, A., Shah, M. A., & Agarwal, I. (2022). Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Questions. Pediatric nephrology (Berlin, Germany), . https://doi.org/10.1007/s00467-021-05357-5
Mathew, Georgie, et al. "Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Questions." Pediatric nephrology (Berlin, Germany) vol. (2022). doi: https://doi.org/10.1007/s00467-021-05357-5
Mathew G, Yasmeen MS, Deepthi RV, Swain M, Vattam A, Shah MA, Agarwal I. Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Questions. Pediatr Nephrol. 2022 Jan 09; doi: 10.1007/s00467-021-05357-5. Epub 2022 Jan 09. PMID: 34999981.
Copy Download .nbib Format: NLM
Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Answers.

Pediatric nephrology (Berlin, Germany)

Mathew G, Yasmeen MS, Deepthi RV, Swain M, Vattam A, Shah MA, Agarwal I.
PMID: 34999987
Pediatr Nephrol. 2022 Jan 09; doi: 10.1007/s00467-021-05377-1. Epub 2022 Jan 09.

No abstract available.

Cite
Mathew G, Yasmeen MS, Deepthi RV, et al. Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Answers. Pediatr Nephrol. 2022;doi: 10.1007/s00467-021-05377-1.
Mathew, G., Yasmeen, M. S., Deepthi, R. V., Swain, M., Vattam, A., Shah, M. A., & Agarwal, I. (2022). Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Answers. Pediatric nephrology (Berlin, Germany), . https://doi.org/10.1007/s00467-021-05377-1
Mathew, Georgie, et al. "Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Answers." Pediatric nephrology (Berlin, Germany) vol. (2022). doi: https://doi.org/10.1007/s00467-021-05377-1
Mathew G, Yasmeen MS, Deepthi RV, Swain M, Vattam A, Shah MA, Agarwal I. Infantile nephrotic syndrome, immunodeficiency and adrenal insufficiency-a rare cause: Answers. Pediatr Nephrol. 2022 Jan 09; doi: 10.1007/s00467-021-05377-1. Epub 2022 Jan 09. PMID: 34999987.
Copy Download .nbib Format: NLM
Renal function of intensive care unit patients: plasma creatinine and urinary retinol-binding protein.

Revista Brasileira de terapia intensiva

Mizoi CS, Dezoti C, Vattimo Mde F.
PMID: 25307244
Rev Bras Ter Intensiva. 2008 Dec;20(4):385-93.

OBJECTIVES: The early assessment of renal dysfunction using common markers does not provide either a sensitive or specific indication of renal dysfunction in critically ill patients. More specific and sensitive markers are desirable for the early detection of an...

Cite
Mizoi CS, Dezoti C, Vattimo Mde F. Função renal de pacientes de unidade de terapia intensiva: creatinina plasmática e proteína carreadora do retinol urinário. Renal function of intensive care unit patients: plasma creatinine and urinary retinol-binding protein. Rev Bras Ter Intensiva. 2008;20(4):385-93
Mizoi, C. S., Dezoti, C., & Vattimo, M. d. e. . F. (2008). Função renal de pacientes de unidade de terapia intensiva: creatinina plasmática e proteína carreadora do retinol urinário. Renal function of intensive care unit patients: plasma creatinine and urinary retinol-binding protein. Revista Brasileira de terapia intensiva, 20(4), 385-93.
Mizoi, Cristina Satoko, et al. "Função renal de pacientes de unidade de terapia intensiva: creatinina plasmática e proteína carreadora do retinol urinário." Renal function of intensive care unit patients: plasma creatinine and urinary retinol-binding protein. Revista Brasileira de terapia intensiva vol. 20,4 (2008): 385-93.
Mizoi CS, Dezoti C, Vattimo Mde F. Função renal de pacientes de unidade de terapia intensiva: creatinina plasmática e proteína carreadora do retinol urinário. Renal function of intensive care unit patients: plasma creatinine and urinary retinol-binding protein. Rev Bras Ter Intensiva. 2008 Dec;20(4):385-93. Portuguese. PMID: 25307244.
Copy Download .nbib Format: NLM
Renoprotective effect of statin: a ischemia-reperfusion animal model.

Revista Brasileira de terapia intensiva

Teshima CA, Watanabe M, Nakamura SH, Vattimo Mde F.
PMID: 25302430
Rev Bras Ter Intensiva. 2010 Sep;22(3):245-9.

OBJECTIVE: Ischemic acute kidney injury (iLRA), with multifatorial cause, presents alarming morbidity and mortality. Statin, HMG-CoA inhibition reductase has shown a renoprotective effect, with antioxidant, antiinflamatory and vascular actions. The heme oxygenase-1 (HO-1) can be involved in these pleitropic...

Cite
Teshima CA, Watanabe M, Nakamura SH, et al. Efeito renoprotetor da estatina: modelo animal de isquemia-reperfusão. Renoprotective effect of statin: a ischemia-reperfusion animal model. Rev Bras Ter Intensiva. 2010;22(3):245-9
Teshima, C. A., Watanabe, M., Nakamura, S. H., & Vattimo, M. d. e. . F. (2010). Efeito renoprotetor da estatina: modelo animal de isquemia-reperfusão. Renoprotective effect of statin: a ischemia-reperfusion animal model. Revista Brasileira de terapia intensiva, 22(3), 245-9.
Teshima, Claudia Akemi Shibuya, et al. "Efeito renoprotetor da estatina: modelo animal de isquemia-reperfusão." Renoprotective effect of statin: a ischemia-reperfusion animal model. Revista Brasileira de terapia intensiva vol. 22,3 (2010): 245-9.
Teshima CA, Watanabe M, Nakamura SH, Vattimo Mde F. Efeito renoprotetor da estatina: modelo animal de isquemia-reperfusão. Renoprotective effect of statin: a ischemia-reperfusion animal model. Rev Bras Ter Intensiva. 2010 Sep;22(3):245-9. Portuguese. PMID: 25302430.
Copy Download .nbib Format: NLM
Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy.

Pharmaceutics

Parisi OI, Ruffo M, Malivindi R, Vattimo AF, Pezzi V, Puoci F.
PMID: 31947815
Pharmaceutics. 2020 Jan 03;12(1). doi: 10.3390/pharmaceutics12010041.

Cytotoxic agents that are used conventionally in cancer therapy present limitations that affect their efficacy and safety profile, leading to serious adverse effects. In the aim to overcome these drawbacks, different approaches have been investigated and, among them, theranostics...

Cite
Parisi OI, Ruffo M, Malivindi R, et al. Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics. 2020;12(1)doi: 10.3390/pharmaceutics12010041.
Parisi, O. I., Ruffo, M., Malivindi, R., Vattimo, A. F., Pezzi, V., & Puoci, F. (2020). Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics, 12(1), . https://doi.org/10.3390/pharmaceutics12010041
Parisi, Ortensia Ilaria, et al. "Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy." Pharmaceutics vol. 12,1 (2020). doi: https://doi.org/10.3390/pharmaceutics12010041
Parisi OI, Ruffo M, Malivindi R, Vattimo AF, Pezzi V, Puoci F. Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy. Pharmaceutics. 2020 Jan 03;12(1). doi: 10.3390/pharmaceutics12010041. PMID: 31947815; PMCID: PMC7022407.
Copy Download .nbib Format: NLM
Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View.

Therapeutic innovation & regulatory science

Parab AA, Mehta P, Vattikola A, Denney CK, Cherry M, Maniar RM, Kjaer J.
PMID: 32128701
Ther Innov Regul Sci. 2020 Sep;54(5):1141-1151. doi: 10.1007/s43441-020-00138-y. Epub 2020 Mar 03.

For almost a decade, regulators and pharmaceutical industry groups have been interested in electronic source (eSource) in clinical trials (Nordo et al. in Learn Health Syst 3:e10076, 2019). eSource may provide efficiencies and value; however, eSource adoption is fragmented...

Cite
Parab AA, Mehta P, Vattikola A, et al. Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View. Ther Innov Regul Sci. 2020;54(5):1141-1151doi: 10.1007/s43441-020-00138-y.
Parab, A. A., Mehta, P., Vattikola, A., Denney, C. K., Cherry, M., Maniar, R. M., & Kjaer, J. (2020). Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View. Therapeutic innovation & regulatory science, 54(5), 1141-1151. https://doi.org/10.1007/s43441-020-00138-y
Parab, Abhijit A, et al. "Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View." Therapeutic innovation & regulatory science vol. 54,5 (2020): 1141-1151. doi: https://doi.org/10.1007/s43441-020-00138-y
Parab AA, Mehta P, Vattikola A, Denney CK, Cherry M, Maniar RM, Kjaer J. Accelerating the Adoption of eSource in Clinical Research: A Transcelerate Point of View. Ther Innov Regul Sci. 2020 Sep;54(5):1141-1151. doi: 10.1007/s43441-020-00138-y. Epub 2020 Mar 03. PMID: 32128701; PMCID: PMC7458943.
Copy Download .nbib Format: NLM
Bacterial diversity and predicted enzymatic function in a multipurpose surface water system - from wastewater effluent discharges to drinking water production.

Environmental microbiome

Tiwari A, Hokajärvi AM, Domingo JS, Elk M, Jayaprakash B, Ryu H, Siponen S, Vepsäläinen A, Kauppinen A, Puurunen O, Artimo A, Perkola N, Huttula T, Miettinen IT, Pitkänen T.
PMID: 34022963
Environ Microbiome. 2021 May 22;16(1):11. doi: 10.1186/s40793-021-00379-w.

BACKGROUND: Rivers and lakes are used for multiple purposes such as for drinking water (DW) production, recreation, and as recipients of wastewater from various sources. The deterioration of surface water quality with wastewater is well-known, but less is known...

Cite
Tiwari A, Hokajärvi AM, Domingo JS, et al. Bacterial diversity and predicted enzymatic function in a multipurpose surface water system - from wastewater effluent discharges to drinking water production. Environ Microbiome. 2021;16(1):11doi: 10.1186/s40793-021-00379-w.
Tiwari, A., Hokajärvi, A. M., Domingo, J. S., Elk, M., Jayaprakash, B., Ryu, H., Siponen, S., Vepsäläinen, A., Kauppinen, A., Puurunen, O., Artimo, A., Perkola, N., Huttula, T., Miettinen, I. T., & Pitkänen, T. (2021). Bacterial diversity and predicted enzymatic function in a multipurpose surface water system - from wastewater effluent discharges to drinking water production. Environmental microbiome, 16(1), 11. https://doi.org/10.1186/s40793-021-00379-w
Tiwari, Ananda, et al. "Bacterial diversity and predicted enzymatic function in a multipurpose surface water system - from wastewater effluent discharges to drinking water production." Environmental microbiome vol. 16,1 (2021): 11. doi: https://doi.org/10.1186/s40793-021-00379-w
Tiwari A, Hokajärvi AM, Domingo JS, Elk M, Jayaprakash B, Ryu H, Siponen S, Vepsäläinen A, Kauppinen A, Puurunen O, Artimo A, Perkola N, Huttula T, Miettinen IT, Pitkänen T. Bacterial diversity and predicted enzymatic function in a multipurpose surface water system - from wastewater effluent discharges to drinking water production. Environ Microbiome. 2021 May 22;16(1):11. doi: 10.1186/s40793-021-00379-w. PMID: 34022963; PMCID: PMC8140503.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries